Welcome to LookChem.com Sign In|Join Free

CAS

  • or

146256-98-6

Post Buying Request

146256-98-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

146256-98-6 Usage

Description

Ethyl N-Boc-4-Oxopyrrolidine-3-carboxylate, also known as 1-tert-butyl 3-ethyl 4-oxopyrrolidine-1,3-dicarboxylate, is a white to slightly yellow crystalline powder. It is a valuable research chemical with unique chemical properties that make it suitable for various applications in different industries.

Uses

Used in Pharmaceutical Industry:
Ethyl N-Boc-4-Oxopyrrolidine-3-carboxylate is used as an intermediate in the synthesis of various pharmaceutical compounds. Its unique chemical structure allows for the development of new drugs with potential therapeutic applications.
Used in Chemical Research:
As a research chemical, Ethyl N-Boc-4-Oxopyrrolidine-3-carboxylate is used in the development and testing of new chemical reactions and processes. Its properties make it a valuable tool for understanding the behavior of similar compounds and for advancing the field of organic chemistry.
Used in Material Science:
Ethyl N-Boc-4-Oxopyrrolidine-3-carboxylate may also find applications in the field of material science, where its unique properties can be utilized to develop new materials with specific characteristics, such as improved stability or reactivity.

Check Digit Verification of cas no

The CAS Registry Mumber 146256-98-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,6,2,5 and 6 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 146256-98:
(8*1)+(7*4)+(6*6)+(5*2)+(4*5)+(3*6)+(2*9)+(1*8)=146
146 % 10 = 6
So 146256-98-6 is a valid CAS Registry Number.
InChI:InChI=1/C12H19NO5/c1-5-17-10(15)8-6-13(7-9(8)14)11(16)18-12(2,3)4/h8H,5-7H2,1-4H3

146256-98-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name Ethyl N-Boc-4-Oxopyrrolidine-3-carboxylate

1.2 Other means of identification

Product number -
Other names 1-tert-Butyl 3-Ethyl 4-Oxopyrrolidine-1,3-dicarboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:146256-98-6 SDS

146256-98-6Relevant articles and documents

(S)-2-Amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)propanoic Acid (AMPA) and Kainate Receptor Ligands: Further Exploration of Bioisosteric Replacements and Structural and Biological Investigation

Brogi, Simone,Brindisi, Margherita,Butini, Stefania,Kshirsagar, Giridhar U.,Maramai, Samuele,Chemi, Giulia,Gemma, Sandra,Campiani, Giuseppe,Novellino, Ettore,Fiorenzani, Paolo,Pinassi, Jessica,Aloisi, Anna Maria,Gynther, Mikko,Venskutonyte, Raminta,Han, Liwei,Frydenvang, Karla,Kastrup, Jette Sandholm,Pickering, Darryl S.

supporting information, p. 2124 - 2130 (2018/03/21)

Starting from 1-4 and 7 structural templates, analogues based on bioisosteric replacements (5a-c vs 1, 2 and 6 vs 7) were synthesized for completing the SAR analysis. Interesting binding properties at GluA2, GluK1, and GluK3 receptors were discovered. The requirements for GluK3 interaction were elucidated by determining the X-ray structures of the GluK3-LBD with 2 and 5c and by computational studies. Antinociceptive potential was demonstrated for GluK1 partial agonist 3 and antagonist 7 (2 mg/kg ip).

Preparation method for omarigliptin midbody

-

Paragraph 0030-0032, (2017/07/19)

The invention provides an efficient and simple preparation method for omarigliptin midbody pyrrole and [3,4-c] pyrazol-5(2H,4H,6H)-carboxylic acid tert-butyl ester, wherein the total recovery ratio is close to 50%. The preparation method is easy to operate, the recovery ratio is higher, three produced wastes are less, and the method is suitable for industrialized production.

ANTI-ANGIOGENESIS COMPOUND, INTERMEDIATE AND USE THEREOF

-

, (2016/11/02)

Disclosed are an anti-abnormal proliferation of angiogenesis compound represented by formula I, use and intermediate thereof. The compound has good effect against abnormal proliferation of angiogenesis, and the activity of the compound is produced by inhibiting VEGFR2. The compound can be used for treating diseases, such as wet macular degeneration, inflammation, malignant tumor and the like, caused by abnormity of angiogenesis and protein kinases such as VEGFR2, FGFR2 and the like.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 146256-98-6